13D/13G Filings - Aurinia Pharmaceuticals Inc. (AUPH)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-27
4:14 pm
Sale
2021-01-25 13D Aurinia Pharmaceuticals Inc.
AUPH
ILJIN SNT Co. Ltd. 8,995,439
7.100%
-1,536,675decrease
(-14.59%)
Filing
History
2021-01-26
4:06 pm
Sale
2021-01-22 13D Aurinia Pharmaceuticals Inc.
AUPH
ILJIN SNT Co. Ltd. 10,532,114
8.300%
-1,237,922decrease
(-10.52%)
Filing
History
2020-10-09
4:05 pm
Sale
2020-10-07 13D Aurinia Pharmaceuticals Inc.
AUPH
ILJIN SNT Co. Ltd. 11,770,036
9.300%
-631,491decrease
(-5.09%)
Filing
History
2020-07-23
4:52 pm
Sale
2020-07-22 13D Aurinia Pharmaceuticals Inc.
AUPH
ILJIN SNT Co. Ltd. 12,401,527
10.900%
-1,308,252decrease
(-9.54%)
Filing
History
Goto Prev, 0, 1